(Q34979815)

5 August 2017

title

Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa (English)

1 reference

5 August 2017

0 references

Pseudomonas aeruginosa

0 references

author name string

Marks MI

1

1 reference

5 August 2017

Hammerberg S

2

1 reference

5 August 2017

Greenstone G

3

1 reference

5 August 2017

Silver B

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 September 1976

1 reference

5 August 2017

number of pages

3

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

5 August 2017

volume

10

1 reference

5 August 2017

issue

3

1 reference

5 August 2017

page(s)

399-401

1 reference

Tobramycin (Nebramycin Factor 6): In Vitro Activity Against Pseudomonas aeruginosa

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429760

In Vitro Susceptibility of Pseudomonas aeruginosa to Carbenicillin and the Combination of Carbenicillin and Gentamicin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429760

In Vitro Studies of BB-K8, a New Aminoglycoside Antibiotic

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429760

Is there complete cross-resistance of gram-negative bacilli to gentamicin and tobramycin?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429760

In Vitro Evaluation of Tobramycin, a New Aminoglycoside Antibiotic

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429760

Cross-Resistance of Pseudomonas to Gentamicin and Tobramycin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429760

Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429760

Antimicrobial activity of tobramycin and gentamicin used in combination with cephalothin and carbenicillin.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429760

Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429760

In Vitro Antibacterial Activity of Amikacin, a New Aminoglycoside, Against Clinical Bacterial Isolates from Children

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429760

Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429760

Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429760

In vitro acitivity of sisomicin, an aminoglycoside antibiotic, against clinical isolates

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429760

Antibacterial Activity of Tobramycin against Gram-Negative Bacteria and the Combination of Ampicillin/Tobramycin against <i>E. coli</i>

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429760

Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429760

Tobramycin: comparative in vitro susceptibility studies

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/825026

12 December 2020

inferred from PubMed ID database lookup

Comparative study of tobramycin and gentamicin with special reference to anti-Pseudomonas activity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/825026

12 December 2020

inferred from PubMed ID database lookup

Antibiotic synergy in experimental infection with Pseudomonas. II. The effect of carbenicillin, cephalothin, or cephanone combined with tobramycin or gentamicin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/825026

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.10.3.399

1 reference

release_pordaglawnfzzb6vedufhfxhaa

5 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pordaglawnfzzb6vedufhfxhaa

24 November 2022

mapped directly with Wikidata item

PMC publication ID

429760

1 reference

5 August 2017

1 reference